⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5143009 | 0.76 | — | — | |
| SCHEMBL3292019 | 0.76 | — | — | |
| SCHEMBL1231792 | 0.73 | ATAD2 (0.37) | — | |
| SCHEMBL65897 | 0.73 | — | — | |
| Flucytosine SCHEMBL8160959 | 0.73 | ALDH1A1 (0.37) | — | |
| Flucytosine SCHEMBL24063 | 0.73 | — | — | |
| SCHEMBL22008 | 0.73 | — | — | |
| SCHEMBL30609151 | 0.73 | — | — | |
| SCHEMBL29061386 | 0.73 | — | — | |
| SCHEMBL65486 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107823644-A | A kind of application of NO compound donators in the invasion and attack and transfer ability medicine that suppress the tumour cell rich in thiol molecule are prepared | 福州大学 | 2018-03-23 | — | — | CN | claimed |
| EP-2013344-B1 | ANTISENSE AGENTS COMBINING STRONGLY BOUND BASE - MODIFIED OLIGONUCLEOTIDE AND ARTIFICIAL NUCLEASE | BALTIC TECHNOLOGY DEV LTD (EE) | 2012-08-29 | — | — | EP | claimed |
| US-20120171279-A1 | STRONGLY BOUND BASE-MODIFIED OLIGONUCLEOTIDES | Baltic Technology Development Ltd. (EE) | 2012-07-05 | — | — | US | claimed |
| US-20110171287-A1 | Use of Oligonucleotides with Modified Bases as Antiviral Agents | BALTIC TECHNOLOGY DEVELPMENT, LTD. (EE) | 2011-07-14 | — | — | US | claimed |
| US-20110152346-A1 | Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids | Baltic Technology Development Ltd. (EE) | 2011-06-23 | — | — | US | claimed |
| CN-101983241-A | Use of oligonucleotides with modified bases in hybridization of nucleic acids | BALTIC TECHNOLOGY DEV LTD | 2011-03-02 | — | — | CN | claimed |
| CN-101970662-A | Use of oligonucleotides with modified bases as antiviral agents | BALTIC TECHNOLOGY DEV LTD | 2011-02-09 | — | — | CN | claimed |
| US-7786292-B2 | compounds having a chelating moiety and an oligonucleotide sequence which includes one or more modified nucleobases such as hydroxynucleobases; inhibiting translation of a nucleic acid in an organism | BALTIC TECHNOLOGY DEVELOPMENT, LTD. (EE) | 2010-08-31 | — | — | US | claimed |
| EP-2217705-A2 | USE OF OLIGONUCLEOTIDES WITH MODIFIED BASES IN HYBRIDIZATION OF NUCLEIC ACIDS | Baltic Technology Development, Ltd. (EE) | 2010-08-18 | — | — | EP | claimed |
| EP-2212420-A2 | USE OF OLIGONUCLEOTIDES WITH MODIFIED BASES AS ANTIVIRAL AGENTS | Baltic Technology Development, Ltd. (EE) | 2010-08-04 | — | — | EP | claimed |
| WO-2009144365-A1 | USE OF OLIGONUCLEOTIDES WITH MODIFIED BASES AS ANTIVIRAL AGENTS | BALTIC TECHNOLOGY DEVELOPMENT, LTD. (EE) | 2009-12-03 | — | — | WO | claimed |
| CN-101437943-A | Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease | BALTIC TECHNOLOGY DEV LTD (EE) | 2009-05-20 | — | — | CN | claimed |
| WO-2009060122-A2 | USE OF OLIGONUCLEOTIDES WITH MODIFIED BASES AS ANTIVIRAL AGENTS | BALTIC TECHNOLOGY DEVELOPMENT, LTD. (EE) | 2009-05-14 | — | — | WO | claimed |
| WO-2009060124-A2 | USE OF OLIGONUCLEOTIDES WITH MODIFIED BASES IN HYBRIDIZATION OF NUCLEIC ACIDS | BALTIC TECHNOLOGY DEVELOPMENT, LTD. (EE) | 2009-05-14 | — | — | WO | claimed |
| EP-2013344-A2 | ANTISENSE AGENTS COMBINING STRONGLY BOUND BASE - MODIFIED OLIGONUCLEOTIDE AND ARTIFICIAL NUCLEASE | Baltic Technology Development, Ltd. (EE) | 2009-01-14 | — | — | EP | claimed |
| WO-2007125173-A2 | ANTISENSE AGENTS COMBINING STRONGLY BOUND BASE - MODIFIED OLIGONUCLEOTIDE AND ARTIFICIAL NUCLEASE | BALTIC TECHNOLOGY DEVELOPMENT, LTD. (EE) | 2007-11-08 | — | — | WO | claimed |
| US-20070259830-A1 | Antisense Agents Combining Strongly Bound Base-Modified Oligonucleotide and Artificial Nuclease | BALTIC TECHNOLOGY DEVELOPMENT (EE) | 2007-11-08 | — | — | US | claimed |
| CN-119912512-A | Comprising a trithiophosphate oligonucleotides with internucleoside linkages | 罗氏创新中心哥本哈根有限公司 | 2025-05-02 | — | — | CN | disclosed |
| EP-0288163-A2 | Oligodeoxynucleotides as inhibitors of the replication of retroviruses and the expression of oncogenes | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1988-10-26 | — | — | EP | disclosed |
| WO-1988007544-A1 | INHIBITORS FOR REPLICATION OF RETROVIRUSES AND FOR THE EXPRESSION OF ONCOGENE PRODUCTS | UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) | 1988-10-06 | — | — | WO | disclosed |